| 摘要 |
The present disclosure provides novel mGlu2/3 agonists of formula (I) useful in the treatment of neurological or psychiatric disorders. An example of the compound is (1S,2S,5R,6S)-2-[[(2S)-2-amino-4-methylsulfanyl-butanoyl]amino]spiro[bicyclo[3.1.0]hexane-4,1’-cyclopropane]-2,6-dicarboxylic acid. |
